Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) Stock
Key stats
- Market cap
- $268.34M
- Price / Earnings ratio
- -3.1x
- EPS (TTM)
- -$3.10
- Volume
- Loading
- 52-week high
- $17.96
- 52-week low
- $5.50
Source: third-party data provider, as of November 13, 2026
Compare with ARCT
Recent news

Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3
Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3
ARCT

Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 5, 2026
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 5, 2026
ARCT

NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'
NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'
ARCT

4 RNA Therapeutics Stocks Leading the Next Wave of Innovation
4 RNA Therapeutics Stocks Leading the Next Wave of Innovation
ARCT
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 40.91
- MACD 12/26/9
- -0.79
- EMA 9 of MACD
- -0.73
- MACD histogram
- -0.06
- SMA 50
- $12.74
- Price below SMA 50
- EMA 50
- $11.33
- Price below EMA 50
- SMA 200
- $9.09
- Price above SMA 200
- EMA 200
- $9.55
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 3 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3
Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3
ARCT

Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 5, 2026
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 5, 2026
ARCT

NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'
NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'
ARCT

4 RNA Therapeutics Stocks Leading the Next Wave of Innovation
4 RNA Therapeutics Stocks Leading the Next Wave of Innovation
ARCT

Arcturus Highlights ARCT-810 Phase II Data, Unveils Next-Gen OTC Therapy Platform
Arcturus Highlights ARCT-810 Phase II Data, Unveils Next-Gen OTC Therapy Platform
ARCT

Arcturus Gets Citi Upgrade After Positive Liver Disease Study Data – But BTIG Says Therapy’s Benefit Is Hard To Measure
Arcturus Gets Citi Upgrade After Positive Liver Disease Study Data – But BTIG Says Therapy’s Benefit Is Hard To Measure
ARCT

Arcturus Therapeutics Announces Interim OTC Deficiency Phase 2 Results and Introduces LUNAR 2.0™ Next-Generation mRNA Delivery Platform
Arcturus Therapeutics Announces Interim OTC Deficiency Phase 2 Results and Introduces LUNAR 2.0™ Next-Generation mRNA Delivery Platform
ARCT

Arcturus Therapeutics to Present Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform
Arcturus Therapeutics to Present Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform
ARCT

Arcturus Therapeutics to Participate in Upcoming Investor Conferences
Arcturus Therapeutics to Participate in Upcoming Investor Conferences
ARCT

Arcturus Therapeutics (ARCT) Just Flashed Golden Cross Signal: Do You Buy?
Arcturus Therapeutics (ARCT) Just Flashed Golden Cross Signal: Do You Buy?
ARCT
News tone: automated (AI) classification of the article's content, not a price prediction.
About Arcturus Therapeutics Holdings Inc. Common Stock
No description available.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Joseph E. Payne M.Sc. | Founder, President, CEO & Director | 1972 |
| Dr. Padmanabh Chivukula Ph.D. | Founder, Chief Scientific Officer, COO & Secretary | 1979 |
| Mr. Dennis M. Mulroy | Chief Financial Officer | 1955 |
| Mr. Joseph Roberts | Principal Accounting Officer & Controller | 1983 |
| Mr. Lance Kurata | Chief Legal Officer | — |
| Ms. Neda Safarzadeh | Vice President and Head of IR/PR & Marketing | — |
| Ms. Natasha O. Bowman | Chief Human Resources Officer | — |
| Mr. Kevin T. Skol | Chief Business Officer | — |
| Dr. Igor Smolenov M.D., Ph.D. | Chief Development Officer | — |
| Dr. Ye Zhang | Chief Regulatory & Quality Assurance Officer | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 40.91
- MACD 12/26/9
- -0.79
- EMA 9 of MACD
- -0.73
- MACD histogram
- -0.06
- SMA 50
- $12.74
- Price below SMA 50
- EMA 50
- $11.33
- Price below EMA 50
- SMA 200
- $9.09
- Price above SMA 200
- EMA 200
- $9.55
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
3 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $19.00
- Average
- $19.67
- High
- $20.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +11.9 | -1.2 | ||||||||||
| 2022 | -34.0 | -9.8 | +22.1 | -33.0 | -6.2 | -14.4 | +8.6 | -19.6 | -4.0 | +18.8 | +0.9 | -7.8 |
| 2023 | +26.5 | -26.3 | +47.1 | +3.6 | +4.7 | +5.9 | +22.0 | -13.1 | -19.5 | -25.6 | +27.5 | +26.8 |
| 2024 | -0.4 | +11.8 | -15.0 | -22.7 | +39.1 | -40.1 | -0.8 | -2.2 | +19.7 | -29.8 | +1.9 | -9.0 |
| 2025 | -0.6 | +6.3 | -32.5 | +35.8 | +0.2 | +1.6 | -6.0 | +38.3 | +10.4 | -51.3 | -27.0 | -5.5 |
| 2026 | +19.5 | +11.7 | -7.5 | +9.8 | -8.2 | -13.5 | -16.4 | +146.0 | -15.7 | -16.5 | -1.9 |



